![Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study - eClinicalMedicine Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/44afb792-47fb-48f5-b5ed-b02bbe7c607b/gr1.jpg)
Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study - eClinicalMedicine
![Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis - Annals of Oncology Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d2ee033e-adc6-4020-b0b8-d76d5fa17842/gr1.jpg)
Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis - Annals of Oncology
![Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis | Oncology Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis | Oncology](https://www.frontiersin.org/files/Articles/588314/fonc-10-588314-HTML/image_m/fonc-10-588314-g001.jpg)
Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis | Oncology
![Survival in B-cell primary ocular lymphoma 1997–2014: a population-based study | Journal of Investigative Medicine Survival in B-cell primary ocular lymphoma 1997–2014: a population-based study | Journal of Investigative Medicine](https://jim.bmj.com/content/jim/66/8/1133/F1.large.jpg?width=800&height=600&carousel=1)
Survival in B-cell primary ocular lymphoma 1997–2014: a population-based study | Journal of Investigative Medicine
The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project | Haematologica
![Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio | Scientific Reports Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-64579-z/MediaObjects/41598_2020_64579_Fig3_HTML.png)
Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio | Scientific Reports
![Predictive value of serological factors, maximal standardized uptake value and ratio of Ki67 in patients diagnosed with non‑Hodgkin's lymphoma Predictive value of serological factors, maximal standardized uptake value and ratio of Ki67 in patients diagnosed with non‑Hodgkin's lymphoma](https://www.spandidos-publications.com/article_images/ol/20/4/ol-20-04-11906-g01.jpg)
Predictive value of serological factors, maximal standardized uptake value and ratio of Ki67 in patients diagnosed with non‑Hodgkin's lymphoma
![Overall survival of 104 patients with non-Hodgkin lymphoma after ASCT... | Download Scientific Diagram Overall survival of 104 patients with non-Hodgkin lymphoma after ASCT... | Download Scientific Diagram](https://www.researchgate.net/profile/Luis-Porrata/publication/11874557/figure/fig1/AS:351152924315656@1460732789605/Overall-survival-of-104-patients-with-non-Hodgkin-lymphoma-after-ASCT-as-a-function-of.png)
Overall survival of 104 patients with non-Hodgkin lymphoma after ASCT... | Download Scientific Diagram
![Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients | Bone Marrow Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients | Bone Marrow](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bmt.1705792/MediaObjects/41409_2007_Article_BF1705792_Fig1_HTML.gif)
Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients | Bone Marrow
![Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma - eBioMedicine Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ec2560c7-dc8d-4a26-90d6-6bffdd934fbd/gr1_lrg.jpg)
Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma - eBioMedicine
![Overall survival according to the Follicular Lymphoma International... | Download Scientific Diagram Overall survival according to the Follicular Lymphoma International... | Download Scientific Diagram](https://www.researchgate.net/profile/Bernd-Metzner/publication/5882500/figure/fig2/AS:264602101481473@1440097465361/Overall-survival-according-to-the-Follicular-Lymphoma-International-Prognostic-Index-19.png)
Overall survival according to the Follicular Lymphoma International... | Download Scientific Diagram
The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project | Haematologica
![Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials - André - 2020 - Cancer Medicine - Wiley Online Library Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials - André - 2020 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b3a0a4e8-76dd-4021-a34a-bc392c6c148c/cam43298-fig-0002-m.jpg)
Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials - André - 2020 - Cancer Medicine - Wiley Online Library
![High combined individual and neighborhood socioeconomic status correlated with better survival of patients with lymphoma in post-rituximab era despite universal health coverage - ScienceDirect High combined individual and neighborhood socioeconomic status correlated with better survival of patients with lymphoma in post-rituximab era despite universal health coverage - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2311300616300167-gr2.jpg)